Our Leadership Team

Geoffrey McDonough
Chief Executive Officer

Born 1970. Employed since 2011. M.D., Harvard Medical School, B.Sc. in Biology and B.A. in Philosophy from University of North Carolina.

Other appointments: Board member of Zafgen and PTC Therapeutics. 

Previous positions: Various senior positions within Genzyme Corporation since 2002, most recently as President of Europe, Middle East and Africa 2010–2011. SVP and General Manager, Personalized Genetic Health 2008–2010, Global Business Leader, LSD Therapeutics, US 2005–2008. Before Genzyme he was internist and paediatrician in the US.

Mats-Olof Wallin
Senior Vice President, Chief Financial Officer

Born 1951. Employed since 2013. B.Sc. at the University of Uppsala. 

Previous positions: More than 30 years of experience in the pharmaceutical industry, gained from various executive positions within companies such as Pharmacia, Ortivus and, most recently, Biotage AB (publ) where he held the role of CFO between 2003 and 2011. 

Fredrik Berg
General Counsel and Head of Legal & Intellectual Property, Risk- Safety and Environment Management

Born 1955. Employed since 2001. Master of Law from the University of Stockholm, Sweden.

Previous positions: Head of Legal/Intellectual Property at Pharmacia AB and General Counsel for Pharmacia Europe, Middle East and Africa 1997–2001. Law firm Lindahl 1996–1997. Various positions as company lawyer and head of legal services at KabiVitrum, Procordia, Kabi Pharmacia and Pharmacia & Upjohn 1988–1996. Law firm Tisell & Co 1984–1988.

Lars Dreiøe
Senior Vice President, Chief Quality & Compliance Officer

Born 1967. Employed since 2016 M. Sc. University of Southern Denmark, Executive MBA from Copenhagen Business School. 

Previous positions: 20 years of experience from the biotech and pharmaceutical industry at Lundbeck and Novo Nordisk A/S. Lars joined Sobi from ALK where he held the position as International Head of Quality (2012-2015).

Stefan Fraenkel
Senior Vice President, Head of Corporate Development

Born 1972. Employed since 2009. Ph.D. in International Economics & Management, MBA from Copenhagen Business School and BSc engineering degree from Chalmers University of Technology

Previous positions: Various international senior commercial and business development positions within Wyeth 2001–2009. Before Wyeth, worked as a management consultant.

Kirsti Gjellan
Senior Vice President, Head of Biologics Development & Supply

Born 1963. Employed since 2014. M.Sc. in Pharmacy and PhD in Pharmaceutical Technology from the University of Oslo, Norway. 

Other appointments: Board member of Process Industrial IT and Automation (PiiA), the Swedish National mobilisation of management, innovation and competence

Previous positions: Site Leader Biologics Manufacturing, Managing Director of Pfizer Health AB and member of the Board of Pfizer Health AB 2010-2014. Director Quality Operations at Pfizer 2005-2010. Managerial experience from Pharmaceutical industry during 17 years with AstraZeneca covering Discovery, Proof of Concept, Pharmaceutical Development, Quality Operations in Manufacturing.

Wills Hughes-Wilson
Senior Vice President, Chief Patient Access Officer

Born 1971. Employed since 2012. Honours graduate in Law from University of Durham in the UK.

Previous positions: Vice President Health/Market Access Policy EMEA at Genzyme Corporation, now part of the French Sanofi Group. Executive Director of Emerging Biopharmaceutical Enterprises (EBE), a specialised group of the European Federation of Pharmaceuticals Industries & Associations (EFPIA). Government affairs lead within the European animal health/veterinary medicines industry and Ernst & Young Consulting.


Alan Raffensperger
Senior Vice President, Chief Operating Officer

Born 1960. Employeed since 2012. B.Sc.in Health Service Management, University of Maryland, Baltimore, USA

Other appointments: Chairman of the Board, Pharmanest AB

Previous positions: CEO of Benechill Inc., Executive Director, Head of Nephrology at Amgen International 2008–2010, General Manager of the Nordic and Baltic Region at Amgen 2005–2008, Sales and Marketing Director at Roche Pharmaceuticals 1999–2004, Vice President, Global Marketing Diabetes Care, Roche Diagnostics 1996–1998, Business Director Europe, Diabetes Care at Boehringer Mannheim 1994 –1996. Leading positions within Pharmacia in Sweden and in the US.

Armin Reininger
Senior Vice President, Medical and Scientific Affairs

Born: 1957. Employed since 2017.
MD, PhD , Ludwig-Maximilians Universität München, Germany

Born: 1957

Employed since: 2017

Education: MD, PhD , Ludwig-Maximilians-University Munich, Germany; certified specialist in Transfusion Medicine

Previous positions: Baxter Head of Medical Affairs EMEA Hemophilia, Baxalta Head of Global Medical Affairs Hematology, Baxalta/Shire Head of Medical Affairs EMEA Hematology, Senior Physician University Clinic Munich, Dpt. of Transfusion Medicine and Haemostaseology

Visiting Scientist-Visiting Lecturer Harvard Medical School, Mass. General Hospital, Boston, MA, Visiting Fellow The Scripps Research Institute, La Jolla, CA, Professor of Anatomy at the Ludwig Maximilians-University Munich, Germany.

Dennis Schmidt Pedersen
Senior Vice President Human Resources

Born 1970. Employed since 2013. Educational background as officer, specialised in leadership development, analytical studies and tactics at the Royal Danish Officers Academy.

Previous positions: Long experience of transformation of local HR models to more integrated international operating models, gained from various leading HR positions in several international companies including Genzyme, Ferring Pharmaceuticals and A.P. Møller-Mærsk. Joined Sobi from Takeda, where he held the position as Director Human Resources, Northern Europe.

Milan Zdravkovic
Senior Vice President, Head of Research & Development

Born: 1970. Employed since: 2016 MD, PhD University of Aarhus, Denmark, MSc Pharmaceutical Medicine, University of Surrey, United Kingdom

Other appointments: DIA Advisory Council Europe, Middle East and Africa. Board member and co-founder of Selma Diagnostics Aps

Previous positions: Corporate Vice President, Novo Nordisk. 18 year tenure in the Research and Development organisation at Novo Nordisk responsible for therapeutic areas including diabetes, devices, growth hormone deficiency, obesity and immunology. Experience from early stage drug development to post-approval life-cycle management.

Opouštíte webové stránky SOBI

Společnost SOBI již dále nenese odpovědnost za obsah ani funkčnost internetových stránek jiných subjektů.

Přejete si opustit stránky?

Ano    Ne